ArticleGynecologic oncology reports2025

Patient with HR-proficient advanced ovarian cancer achieved a complete response with Cadonilimab combined chemotherapy (PD-1/CTLA-4 bispecific): a case report and literature review.

Chenge Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.